Daniel N. Egan, MD | Seattle, WA

Dr. Daniel Egan, MD

Claim this profile

Swedish Cancer Institute

Studies Acute Myelogenous Leukemia
Studies Acute Myeloid Leukemia
6 reported clinical trials
7 drugs studied

Area of expertise

1

Acute Myelogenous Leukemia

Daniel Egan, MD has run 4 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:

Stage II
Stage I
2

Acute Myeloid Leukemia

Daniel Egan, MD has run 3 trials for Acute Myeloid Leukemia. Some of their research focus areas include:

Stage II
Stage I

Affiliated Hospitals

Image of trial facility.

Swedish Cancer Institute

Image of trial facility.

Swedish Health Services

Clinical Trials Daniel Egan, MD is currently running

More about Daniel Egan, MD

Clinical Trial Related

4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Daniel Egan, MD has experience with

  • CC-96191
  • CC-95266
  • Azacitidine
  • Tamibarotene
  • SEA-CD70
  • CYNK-001

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Daniel Egan, MD specialize in?

Is Daniel Egan, MD currently recruiting for clinical trials?

Are there any treatments that Daniel Egan, MD has studied deeply?

What is the best way to schedule an appointment with Daniel Egan, MD?

What is the office address of Daniel Egan, MD?

Is there any support for travel costs?